CryoCath buys Endocare's cardiac ablation technology
This article was originally published in Clinica
Executive Summary
CryoCath hopes to improve its gross margins as a result of the acquisition of Endocare's SurgiFrost surgical probe system for ablating cardiac arrhythmias. It has marketed the product - which uses a malleable, single-use cryosurgical probe - since its launch in June 2002, and says that manufacturing the product in-house will reduce expenses.